Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Growth factor has metabolic and hemodynamic effects, including a direct lipolytic effect that reduces fat depots, suggesting potential therapeutic applications in obesity.
Significant congenital deficiency of growth factor (GF) results in pituitary nanism (dwarfism) and its substantial excess is accompanied by the development of gigantism or acromegaly. Its impact on the growth of the whole body or its individual parts is impossible without affecting metabolic processes and hemodynamic parameters. A number of investigations have proven that GF has a direct lipolytic effect: adequate replacement therapy for pituitary nanism gives rise to a reduction in fat depots. Since the concentration of GF is lower in obesity, Whether it may be used to treat this abnormality is considered.
No takes yet. Share an insight, caveat, or question.
Manhylova et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: